US’ 1st Awake Patient Kidney Transplant with Next Day Discharge
Read about the groundbreaking awake patient kidney transplant in the US, where John Nicholas received a kidney from his childhood friend and was discharged within 24 hours post-surgery. The unique procedure, using spinal anesthesia, lasted less than two hours and marked a significant advancement in kidney transplant surgery.
The Legacy of Richard ‘Rick’ Slayman: First Man to Receive Pig Kidney Transplant
Discover the groundbreaking story of Richard ‘Rick’ Slayman, the first man to undergo a genetically modified pig kidney transplant. Despite his passing, his journey offers hope and inspiration for the future of xenotransplantation and the potential of genetically modified animals in organ transplants.
Groundbreaking In-Utero Kidney Tissue Transplantation Milestone Achieved in Japan
Scientists in Japan have achieved a groundbreaking milestone in the field of medicine by successfully transplanting kidney tissue between rat fetuses while still in the uterus. This remarkable feat, although yet to undergo peer review, marks a significant advancement that could pave the way for future in-utero xenotransplantation in humans. The study aims to address the neonatal condition known as Potter sequence, offering a potential solution to kidney-related complications in infants. Lead author Takashi Yokoo described the project as groundbreaking, with a success rate of 88% in transplanted kidneys. The research holds promise for future in-utero medical interventions in both animals and humans.
Groundbreaking Pig Kidney Transplant Marks Milestone in Medicine
Read about the groundbreaking medical procedure at Massachusetts General Hospital where a genetically modified pig kidney was successfully transplanted into a 62-year-old man suffering from end-stage kidney disease. This innovative operation marks a significant advancement in the field of medicine, with potential implications for the future of organ transplantation.
Man Discharged After Receiving Genetically Modified Pig Kidney Transplant
The first man to receive a genetically modified pig kidney transplant has been discharged from Massachusetts General Hospital after a successful surgery. The historic procedure is being celebrated as a significant milestone in the field of transplantation, offering hope to thousands of people in need of transplants. The pig kidney, modified by eGenesis, was approved for use under a compassionate use protocol, potentially addressing the world’s organ shortage.
Man recovering well after receiving genetically modified pig kidney
62-year-old Rick Slayman received a genetically modified pig kidney in a pioneering transplant surgery, marking a major milestone in organ availability. With a chronic shortage of human donor organs, animal donors may provide hope for thousands in need of transplants. The special pig kidney was provided by eGenesis of Cambridge, Massachusetts, and Mr. Slayman’s recovery is being closely monitored as he continues to take anti-rejection drugs.
HI-Bio™ Receives Orphan Drug Designation for Felzartamab Targeted Therapy
HI-Bio™ has received Orphan Drug Designation from the FDA for felzartamab, a targeted therapy for antibody-mediated rejection in kidney transplant recipients. This designation is a significant milestone in addressing the critical unmet medical need for AMR, with potential breakthrough implications. The Orphan Drug Designation qualifies HI-Bio for certain development incentives, expected to accelerate the development of felzartamab and enhance the company’s ability to bring this innovative therapy to patients in need.